S.-Z. Lu, H.-H. Yang, W.-J. Chang et al.
Journal of Organometallic Chemistry 927 (2020) 121543
all reflections. Data reduction was performed with the DENZO–SMN
[27] software. Empirical absorption correction was based on the
symmetry-equivalent reflections and was applied to the data us-
ing the SORTAV [28] program. Structural analysis was made using
the SHELXTL program on a personal computer. The structure was
solved using the SHELXS-97 [29] program and refined using the
SHELXL-97 [30] program by a full–matrix least–squares method on
F2 values. All non-hydrogen atoms were refined anisotropically. Ex-
cept for the amido hydrogens in 5, which were found and refined
isotropically, all the other hydrogen atoms were fixed at calculated
positions and refined using a riding mode. Crystal data and struc-
ture refinement for the different compounds are given in support-
ing information. Crystal data, details of data collection and struc-
ture refinement for compounds 4-7 (CCDC 2014566-2014570) can
be obtained from the Cambridge Crystallographic Data Centre via
NiCl2(CH3CN)2 (105.8 mg, 0.5 mmol), K2CO3 (276.0 mg, 2.0
mmol), and MeOH (20 mL). The solution was refluxed for 1.5
h. The green solution changed color to yellow with formation
of a yellow precipitate. After cooling, the solvent was removed,
and the solid was washed with 100 mL of deionized water, then
re-dissolved in methanol and filtered through a pad of Celite. The
solvent was removed resulting in 180.0 mg of light yellow solid
(0.41 mmol, 83% yield). Slow diffusion of ether into a solution
of compound in methanol - chloroform afforded orange crystals
suitable for X-ray diffraction analysis. Mp: 324-329°C. 1H NMR
(DMSO–d6): δ 7.80 (d, J = 7.7 Hz, 1H, C6H4), 7.55 (d, J = 7.7 Hz,
1H, C6H4), 7.35 (m, 2H, C6H4), 5.19 (d, J = 16.3 Hz, 1H, CH2), 4.75
(d, J = 16.3 Hz, 1H, CH2), 4.49 (s, 1H, NH), 3.31 (s, 3H, CH3). 1H
NMR (DMSO–d6, 120 C): δ 7.70 (d, J = 6.7 Hz, 1H, C H ), 7.52
º
6
4
(d, J = 7.5 Hz, 1H, C6H4), 7.36 (m, 2H, C6H4), 4.94 (br s, 2H, CH2),
3.89 (br s, 1H, NH), 3.38 (s, 3H, CH3). 13C NMR (DMSO–d6): δ
178.55 (NCN), 170.83 (C=O), 134.57, 133.85 (C=C), 123.94, 123.56,
111.37, 111.01 (C6H4), 50.64 (CH2), 33.89 (CH3). IR (KBr): 3330(vw),
3203(vw), 3059(vw), 3035(vw), 2941(vw), 2925(vw), 2865(vw),
1624(s), 1586(vs), 1460(w), 1433(vw), 1385(s), 1344(vw), 1312(w),
1257(vw), 1207(vw), 1174(vw), 1150(vw), 1130(vw), 1092(vw),
1026(vw), 1012(vw), 982(vw), 927(vw), 848(vw), 796(vw), 757(w),
733(vw), 689(vw), 584(vw), 571(vw), 558(vw) cm−1. Anal. Calc.
For C20H22N6O3Ni: C, 53.01; H, 4.89; N, 18.55. Found: C, 52.93; H,
4.96; N, 18.44%.
4.3. Preparations of complexes
4.3.1. Preparation of 1-acetamido-3-phenylbenzimidazolium bromide
(1)
1-Phenylbenzimidazole
(2.042
g,
10.5
mmol),
2-
bromoacetamide (1.518 g, 11.0 mmol) and acetonitrile (25 mL)
were placed into a 50 mL flask. The mixture was refluxed for
2
days followed by the solvent removal. The remaining solid
was washed thrice with 20 mL portions of dichloromethane. The
washed solid was dried resulting in 3.089 g of white powder (9.3
mmol, 89% yield). 1H NMR (DMSO–d6, 400 MHz,): δ 10.39 (s,
1H, NCHN), 8.15 (br s, 1H, NH2), 8.09 (d, J = 8.0 Hz, 1H, C6H4),
7.86 (m, 3H, Ph, C6H4), 7.75 (m, 6H, Ph, C6H4, NH2), 5.47 (s, 2H,
CH2). 13C NMR (DMSO–d6, 100 MHz): δ 166.66 (C=O), 144.02
(NCN), 133.46, 132.25 (C=C), 131.15, 131.08, 130.99 (Ph), 127.94,
127.65 (C6H4), 125.56 (Ph), 114.66, 113.97 (C6H4), 49.29 (CH2). IR
(KBr): 3313(vw), 3294(vw), 3141(w), 2945(m), 2802(vw), 2742(vw),
2506(vw), 1838(vw), 1704(vs), 1693(s), 1566(w), 1561(w), 1406(w),
1385(s), 1306(vw), 1257(w), 1207(vw), 1081(vw), 1029(vw),
1020(vw), 862(vw), 781(w), 761(m), 694(vw), 669(vw), 662(vw),
and 585(vw) cm−1. Anal. Calc. For C15H14 BrN3O: C, 54.23; H, 4.25;
N, 12.65. Found: C, 54.30; H, 4.01; N, 12.64%.
4.3.4. Preparation of [Ni(Et-bimy-CH2CONH)2] (4)
Complex 4 was prepared analogously to complex 3 from 1-
acetamido-3-ethylbenzimidazolium bromide (284.2 mg, 1.0 mmol),
NiCl2(CH3CN)2 (106.0 mg, 0.5 mmol), K2CO3 (276.0 mg, 2.0 mmol),
and MeOH (20 mL) as a light yellow solid (190.0 mg, 0.41 mmol,
82% yield). Slow diffusion of ether into a methanol solution of the
compound afforded orange crystals suitable for X-ray diffraction
analysis. Mp: 292-296°C. 1H NMR (DMSO–d6): δ 7.83 (d, J = 7.9
Hz, 1H, C6H4), 7.63 (d, J = 7.9 Hz, 1H, C6H4), 7.34 (m, 2H, C6H4),
5.09 (d, J = 16.4 Hz, 1H, CH2(amide)), 4.78 (d, J = 16.4 Hz, 1H,
CH2(amide)), 4.52 (br s, 1H, NH), 4.31 (m, 1H, CH2(ethyl)), 3.59 (m,
1H, CH2(ethyl)), 1.19 (t, J = 7.1 Hz, 3H, CH3). 1H NMR (DMSO–d6,
180 C): δ 7.68 (d, J = 7.9 Hz, 1H, C H ), 7.54 (d, J = 7.9 Hz,
º
6
4
1H, C6H4), 7.36 (m, 2H, C6H4), 4.92 (s, 2H, CH2(amide)), 4.00 (q,
J = 5.6 Hz, 2H, CH2(ethyl)), 3.72 (br s, 1H, NH), 1.36 (t, J = 7.1
Hz, 3H, CH3). 13C NMR (DMSO–d6): δ 178.43 (NCN), 170.90 (C=O),
134.28, 133.57 (C=C), 123.99, 123.66, 111.31, 111.25 (C6H4), 50.79
(CH2(amide)), 42.79 (CH2(ethyl)), 15.35 (CH3). IR (KBr): 3340(vw),
3246(vw), 3065(vw), 3034(vw), 2988(vw), 2965(vw), 2931(vw),
2867(vw), 1618(s), 1589(vs), 1476(vw), 1449(w), 1396(m), 1385(m),
1336(vw), 1305(w), 1270(vw), 1237(vw), 1207(vw), 1191(vw),
1169(vw), 1111(vw), 1081(vw), 1034(vw), 1012(vw), 979(vw),
930(vw), 881(vw), 845(vw), 818(vw), 776(vw), 758(w), 745(w),
719(vw), 612(vw) cm−1. Anal. Calc. for C22H25N6O2.5Ni: C, 55.96;
H, 5.34; N, 17.80. Found: C, 55.90; H, 5.18; N, 17.85%.
4.3.2. Preparation of 1-acetamido-3-(2-pyridyl)benzimidazolium
bromide (2)
A mixture of 1-(2-pyridyl)benzimidazole (3.123 g, 16.0 mmol)
and 2-bromoacetamide (2.208 g, 16.0 mmol) in THF (25 mL) was
refluxed for 2 days to form a white precipitate. The precipitate
was isolated by filtration and washed with THF repeatedly. The
resulting white solid was dried to result in 3.902 g of white
powder (11.7 mmol, 73% yield). 1H NMR (DMSO–d6, 400 MHz): δ
10.60 (s, 1H, NCHN) 8.78 (d, J = 4.8 Hz, 1H, py), 8.45 (m, 1H, py),
8.29 (td, J = 7.8 Hz, J=1.8 Hz, 1H, py), 8.07 (m, 3H, py+NH2), 7.76
(m, 4H, C6H4+NH2), 5.43 (s, 2H, CH2). 13C NMR (DMSO–d6, 100
MHz): δ 166.52 (C=O), 150.07 (py), 147.56 (NCN), 143.81, 141.20
(py), 132.63 (C=C), 129.64 (C=C), 128.18, 127.81 (C6H4), 125.79
(py), 117.62 (C6H4), 116.22 (py), 114.65 (C6H4), 49.42 (CH2). IR
(KBr): 3786(w), 3691(vw), 3349(s), 3172(vw), 2954(m), 2808(vw),
2687(vw), 2604(vw), 2382(vw), 2299(vw), 1684(vs), 1559(w),
1484(vw), 1463(vw), 1441(vw), 1399(w), 1355(vs), 1342(vw),
1334(vw), 1308(w), 1286(vw), 1261(m), 1218(w), 1180(vw),
1157(vw), 1132(vw), 1099(vw), 1051(w), 890(vw), 854(w), 827(vw),
786(m), 757(vw), 743(vw), 721(vw), 672(w), 573(vw), and 512(vw)
cm−1. Anal. Calc. For C14 H13BrN4O: C, 50.47; H, 3.93; N, 16.82.
Found: C, 50.43; H, 4.00; N, 16.79%.
4.3.5. Preparation of [Ni(Ph-bimy-CH2CONH)2] (5)
A
50 mL flask was charged with 1-acetamido-3-
phenylbenzimidazolium bromide (332.2 mg, 1.0 mmol), Ni(OAc)2
(88.2 mg, 0.5 mmol), and TBAB (1.0 g). The solution was heated
to 130 C for 3 h. The solid dissolved yielding a green solution.
º
The solution was cooled to room temperature and an orange
precipitate was formed. The resulting solid was washed with
100 mL of deionized water, and then dissolved in methanol and
filtered through a pad of Celite. After the solvent was removed,
90.2 mg of light yellow solid (0.16 mmol, 32% yield) was obtained.
Crystals suitable for X-ray diffraction analysis were isolated from
methanol solution. Mp: 303-306°C. 1H NMR (DMSO–d6): δ 7.88
(br s, 2H, Ph), 7.50 (d, J = 8.0 Hz, 1H, C6H4), 7.36 (br s, 2H, Ph),
7.26 (t, J = 7.1 Hz, 1H, C6H4), 7.19 (m, 3H, Ph+C6H4), 4.62 (br
4.3.3. Preparation of [Ni(Me-bimy-CH2CONH)2] (3)
A
50 mL flask was charged with 1-acetamido-3-
methylbenzimidazolium bromide (270.8 mg, 1.0 mmol),
8